Browsing Tag
Summit Therapeutics Inc.
8 posts
Wall Street top gainers: WeRide, XPeng, Dycom, GDS lead the charge as markets slide
Find out which stocks defied the selloff on May 21, 2025. WeRide, XPeng, and Dycom surged amid market turbulence. Full gainer list and investor analysis.
May 22, 2025
Saia, BioNTech, and AppFolio stocks plunge amid trade war fallout
Explore why top U.S. stocks crashed on April 25, 2025, as tariffs, recession risks, and institutional selloffs rattled Wall Street. Read full sector analysis.
April 26, 2025
Wall Street rebounds: What ServiceNow, Hasbro, Microchip, and other top gainers signal for investors
See which 20+ US stocks soared on April 24, 2025, as investors rotated into tech, healthcare, and industrials amid strong earnings and improving sentiment.
April 25, 2025
Wall Street rally: Pegasystems, Summit Therapeutics among top gainers as trade optimism lifts US stocks
Find out how Pegasystems, Summit Therapeutics, and Tempus AI surged on April 23, 2025, as tariff cuts and AI optimism drove major gains across US stock markets.
April 24, 2025
Top stock market trends – Eli Lilly jumps $105, Hertz explodes 44%, Trump Media rallies again
Explore why Hertz, Eli Lilly, and Trump Media led the top U.S. stock market gainers on April 17, 2025. Get key data, economic context, and investor insights now.
April 19, 2025
Wall Street rally shocks markets as 25 stocks post double-digit gains after Trump tariff twist
See which U.S. stocks surged on April 14, 2025, and why tariff relief, energy optimism, and healthcare innovation pushed markets higher.
April 15, 2025
Gold miners, biotech, and EV firms lead top US stock gainers as inflation cools and investors shift towards defensive bets
Gold, biotech, and China EV stocks led April 10’s US gainers as inflation cooled and investor focus shifted to safe-haven and growth resilience sectors.
April 11, 2025
Why New Fortress Energy, Rocket Companies, and Avidity Biosciences are surging despite economic warnings
Find out which US stocks surged on April 2, 2025, and what rising tariffs and policy shifts mean for investors navigating today’s volatile market.
April 3, 2025